is compounded semaglutide a glp-1 Program: Results, Timeline & Comparison Compounded Semaglutide: Legal & Safe

20% Reduced Cardiac Risk The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in patients with obesity and heart disease

Compounded drugs do not undergo the same amount of testing for safety, effectiveness, and quality that FDA-approved drugs do, so they naturally pose a higher risk to people taking them

Possible options include: antacids to neutralise stomach acid acid-reducing medications such as H2 blockers or proton pump inhibitors digestive support strategies recommended by a clinician These treatments should always be used under professional guidance to ensure safe and appropriate symptom management

Medical nutrition therapy may be covered by your insurance plan